Cases & Deals

King Pharmaceuticals files patent infringement suit against Mutual over generic version of Skelaxin®

Clients King Pharmaceuticals, Inc.

Jones Day represented King Pharmaceuticals in a Hatch-Waxman patent infringement action against Mutual Pharmaceutical Co. Inc. concerning several patents related to Skelaxin®, which is used in the treatment of musculoskeletal disorders.

King Pharmaceuticals, Inc. v. Mutual Pharmaceuticals Co., Inc. (E.D. Pa. 2004)

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.